Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
ACS Appl Mater Interfaces ; 13(41): 48469-48477, 2021 Oct 20.
Article in English | MEDLINE | ID: covidwho-1461961

ABSTRACT

The COVID-19 pandemic highlighted the importance of developing surfaces and coatings with antiviral activity. Here, we present, for the first time, peptide-based assemblies that can kill viruses. The minimal inhibitory concentration (MIC) of the assemblies is in the range tens of micrograms per milliliter. This value is 2 orders of magnitude smaller than the MIC of metal nanoparticles. When applied on a surface, by drop casting, the peptide spherical assemblies adhere to the surface and form an antiviral coating against both RNA- and DNA-based viruses including coronavirus. Our results show that the coating reduced the number of T4 bacteriophages (DNA-based virus) by 3 log, compared with an untreated surface and 6 log, when compared with a stock solution. Importantly, we showed that this coating completely inactivated canine coronavirus (RNA-based virus). This peptide-based coating can be useful wherever sterile surfaces are needed to reduce the risk of viral transmission.


Subject(s)
Antiviral Agents/chemistry , Peptides/chemistry , Animals , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Bacteriophages/drug effects , COVID-19/virology , Coronavirus/drug effects , Coronavirus/isolation & purification , Coronavirus Infections/drug therapy , Coronavirus Infections/virology , Dihydroxyphenylalanine/chemistry , Dog Diseases/drug therapy , Dog Diseases/virology , Dogs , Humans , Metal Nanoparticles/chemistry , Peptides/pharmacology , Peptides/therapeutic use , SARS-CoV-2/isolation & purification , Virus Inactivation/drug effects , COVID-19 Drug Treatment
2.
J Hosp Infect ; 112: 108-113, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1185068

ABSTRACT

BACKGROUND: The presence of coronaviruses on surfaces in the patient environment is a potential source of indirect transmission. Manual cleaning and disinfection measures do not always achieve sufficient removal of surface contamination. This increases the importance of automated solutions in the context of final disinfection of rooms in the hospital setting. Ozone is a highly effective disinfectant which, combined with high humidity, is an effective agent against respiratory viruses. Current devices allow continuous nebulization for high room humidity as well as ozone production without any consumables. AIM: In the following study, the effectiveness of a fully automatic room decontamination system based on ozone was tested against bacteriophage Φ6 (phi 6) and bovine coronavirus L9, as surrogate viruses for the pandemic coronavirus SARS-CoV-2. METHODS: For this purpose, various surfaces (ceramic tile, stainless steel surface and furniture board) were soiled with the surrogate viruses and placed at two different levels in a gas-tight test room. After using the automatic decontamination device according to the manufacturer's instructions, the surrogate viruses were recovered from the surfaces and examined by quantitative cultures. Then, reduction factors were calculated. FINDINGS: The ozone-based room decontamination device achieved virucidal efficacy (reduction factor >4 log10) against both surrogate organisms regardless of the different surfaces and positions confirming a high activity under the used conditions. CONCLUSION: Ozone is highly active against SARS-CoV-2 surrogate organisms. Further investigations are necessary for a safe application and efficacy in practice as well as integration into routine processes.


Subject(s)
Automation/instrumentation , COVID-19/prevention & control , Disinfectants/pharmacology , Disinfection/instrumentation , Disinfection/methods , Ozone/pharmacology , Animals , Bacteriophages/drug effects , COVID-19/transmission , Cattle , Coronavirus, Bovine/drug effects , Cross Infection/prevention & control , Cross Infection/virology , Decontamination/instrumentation , Decontamination/methods , Equipment and Supplies, Hospital/virology , Hospitals , Humans , SARS-CoV-2/drug effects
3.
Int J Mol Sci ; 22(4)2021 Feb 09.
Article in English | MEDLINE | ID: covidwho-1082973

ABSTRACT

The purpose of the study was to obtain an external coating based on nanoparticles of ZnO, carvacrol, and geraniol that could be active against viruses such as SARS-Co-V2. Additionally, the synergistic effect of the chosen substances in coatings was analyzed. The goal of the study was to measure the possible antibacterial activity of the coatings obtained. Testing antiviral activity with human pathogen viruses, such as SARS-Co-V2, requires immense safety measures. Bacteriophages such as phi 6 phage represent good surrogates for the study of airborne viruses. The results of the study indicated that the ZC1 and ZG1 coatings containing an increased amount of geraniol or carvacrol and a very small amount of nanoZnO were found to be active against Gram-positive and Gram-negative bacteria. It is also important that a synergistic effect between these active substances was noted. This explains why polyethylene (PE) films covered with the ZC1 or ZG1 coatings (as internal coatings) were found to be the best packaging materials to extend the quality and freshness of food products. The same coatings may be used as the external coatings with antiviral properties. The ZC1 and ZG1 coatings showed moderate activity against the phi 6 phage that has been selected as a surrogate for viruses such as coronaviruses. It can be assumed that coatings ZG1 and ZC1 will also be active against SARS-CoV-2 that is transmitted via respiratory droplets.


Subject(s)
Acyclic Monoterpenes/chemistry , Anti-Bacterial Agents/chemistry , Antiviral Agents/chemistry , Cymenes/chemistry , Metal Nanoparticles/chemistry , Zinc Oxide/chemistry , Anti-Bacterial Agents/pharmacology , Antiviral Agents/pharmacology , Bacteriophages/drug effects , COVID-19/pathology , COVID-19/virology , Drug Carriers/chemistry , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria , SARS-CoV-2/drug effects , SARS-CoV-2/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL